GEECF yields 2000000.00% · PFE yields 6.13%● Live data
📍 GEECF pulled ahead of the other in Year 1
Combined, GEECF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GEECF + PFE for your $10,000?
Global Environmental Energy Corp. engages in alternative energy sources, environmental infrastructure, electrical micro-power generation and liquid fuel production. The company also develops and commercializes various technologies in the waste to energy sector, including electrical power generation and liquid fuel production. It offers Biosphere Process System, a waste to energy system that provides solutions for the conversion of waste materials, which includes municipal solid waste, agricultural or forestry surpluses or wastes, industrial or medical waste materials, and traditional fossil fuels in a process that includes automatic separation of metals and plastics, the formation of organic compost, and the heating of the organic residue left from the separation process to high temperatures in a separate chamber, which is deprived of oxygen. The company sells and operates Biosphere Systems in Asia, Europe, the Americas, and the Philippines. Global Environmental Energy Corp. was formerly known as Life Energy & Technology Holdings, Inc. and changed its name to Global Environmental Energy Corp. in Septmber, 2004. The company is based in Nassau, Bahamas. On June 5, 2007, the voluntary petition of Global Environmental Energy Corp. for reorganization under Chapter 11 was converted to Chapter 7. The Company had filed for Chapter 11 bankruptcy on May 19, 2005.
Full GEECF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.